Item 16. Form 10-K Summary
14K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary
None.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| IQVIA HOLDINGS INC. | |||||
| By: /s/ Ronald E. Bruehlman | |||||
| Name: Ronald E. Bruehlman | |||||
| Title: Executive Vice President and Chief | |||||
| Financial Officer |
Date: February 13, 2025
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.
| Signature | Title | Date | ||||||||||||
| /s/ Ari Bousbib | Chairman and Chief Executive Officer; Director | February 13, 2025 | ||||||||||||
| Ari Bousbib | (Principal Executive Officer) | |||||||||||||
| /s/ Ronald E. Bruehlman | Executive Vice President and Chief Financial Officer | February 13, 2025 | ||||||||||||
| Ronald E. Bruehlman | (Principal Financial Officer) | |||||||||||||
| /s/ Keriann Cherofsky | Senior Vice President, Chief Accounting Officer and Corporate Controller | February 13, 2025 | ||||||||||||
| Keriann Cherofsky | (Principal Accounting Officer) | |||||||||||||
| /s/ Carol J. Burt | Director | February 13, 2025 | ||||||||||||
| Carol J. Burt | ||||||||||||||
| /s/ John P. Connaughton | Director | February 13, 2025 | ||||||||||||
| John P. Connaughton | ||||||||||||||
| /s/ John G. Danhakl | Director | February 13, 2025 | ||||||||||||
| John G. Danhakl | ||||||||||||||
| /s/ James A. Fasano | Director | February 13, 2025 | ||||||||||||
| James A. Fasano | ||||||||||||||
| /s/ Colleen A. Goggins | Director | February 13, 2025 | ||||||||||||
| Colleen A. Goggins | ||||||||||||||
| /s/ John M. Leonard, M.D. | Director | February 13, 2025 | ||||||||||||
| John M. Leonard, M.D. | ||||||||||||||
| /s/ Leslie Wims Morris | Director | February 13, 2025 | ||||||||||||
| Leslie Wims Morris | ||||||||||||||
| /s/ Todd B. Sisitsky | Director | February 13, 2025 | ||||||||||||
| Todd B. Sisitsky | ||||||||||||||
| /s/ Sheila A. Stamps | Director | February 13, 2025 | ||||||||||||
| Sheila A. Stamps | ||||||||||||||
(2) Financial Statement Schedules
Schedule I—Condensed Financial Information of Registrant
IQVIA HOLDINGS INC. (PARENT COMPANY ONLY)
CONDENSED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
| Year Ended December 31, | ||||||||||||||||||||
| (in millions) | 2024 | 2023 | 2022 | |||||||||||||||||
| Equity in earnings of subsidiary, net of tax | $ | 1,373 | $ | 1,358 | $ | 1,091 | ||||||||||||||
| Net income | 1,373 | 1,358 | 1,091 | |||||||||||||||||
| Equity in other comprehensive (loss) income of subsidiary, net of tax | (171) | (140) | (321) | |||||||||||||||||
| Comprehensive income | $ | 1,202 | $ | 1,218 | $ | 770 |
IQVIA HOLDINGS INC. (PARENT COMPANY ONLY)
CONDENSED BALANCE SHEETS
| December 31, | ||||||||||||||
| (in millions, except per share data) | 2024 | 2023 | ||||||||||||
| ASSETS | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ | — | $ | 2 | ||||||||||
| Total current assets | — | 2 | ||||||||||||
| Investment in subsidiary | 9,667 | 9,667 | ||||||||||||
| Total assets | $ | 9,667 | $ | 9,669 | ||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ | 9 | $ | 8 | ||||||||||
| Total current liabilities | 9 | 8 | ||||||||||||
| Investment in subsidiary | 3,588 | 3,546 | ||||||||||||
| Payable to subsidiary | 3 | 3 | ||||||||||||
| Total liabilities | 3,600 | 3,557 | ||||||||||||
| Commitments and contingencies | ||||||||||||||
| Stockholders’ equity: | ||||||||||||||
| Common stock and additional paid-in capital, 400.0 shares authorized as of December 31, 2024 and 2023, $0.01 par value, 258.2 shares issued and 176.1 shares outstanding as of December 31, 2024; 257.2 shares issued and 181.5 shares outstanding as of December 31, 2023 | 11,143 | 11,028 | ||||||||||||
| Retained earnings | 6,065 | 4,692 | ||||||||||||
| Treasury stock, at cost, 82.1 and 75.7 shares as of December 31, 2024 and 2023, respectively | (10,103) | (8,741) | ||||||||||||
| Accumulated other comprehensive loss | (1,038) | (867) | ||||||||||||
| Total stockholders’ equity | 6,067 | 6,112 | ||||||||||||
| Total liabilities and stockholders’ equity | $ | 9,667 | $ | 9,669 |
IQVIA HOLDINGS INC. (PARENT COMPANY ONLY)
CONDENSED STATEMENTS OF CASH FLOWS
| Year Ended December 31, | ||||||||||||||||||||
| (in millions) | 2024 | 2023 | 2022 | |||||||||||||||||
| Operating activities: | ||||||||||||||||||||
| Net Income | $ | 1,373 | $ | 1,358 | $ | 1,091 | ||||||||||||||
| Adjustments to reconcile net income to cash provided by operating activities: | ||||||||||||||||||||
| Equity in earnings of subsidiary | (1,373) | (1,358) | (1,091) | |||||||||||||||||
| Change in operating assets and liabilities: | ||||||||||||||||||||
| Other operating assets and liabilities | (11) | — | 1 | |||||||||||||||||
| Net cash from operating activities | (11) | — | 1 | |||||||||||||||||
| Investing activities: | ||||||||||||||||||||
| Investment in subsidiary, net of dividends received | 1,423 | 1,052 | 1,238 | |||||||||||||||||
| Net cash from investing activities | 1,423 | 1,052 | 1,238 | |||||||||||||||||
| Financing activities: | ||||||||||||||||||||
| Payments related to employee stock incentive plans, net | (64) | (61) | (71) | |||||||||||||||||
| Repurchase of common stock | (1,350) | (992) | (1,168) | |||||||||||||||||
| Intercompany with subsidiary | — | 1 | — | |||||||||||||||||
| Net cash from financing activities | (1,414) | (1,052) | (1,239) | |||||||||||||||||
| Change in cash and cash equivalents | (2) | — | — | |||||||||||||||||
| Cash and cash equivalents at beginning of period | 2 | 2 | 2 | |||||||||||||||||
| Cash and cash equivalents at end of period | $ | — | $ | 2 | $ | 2 |
IQVIA HOLDINGS INC. (PARENT COMPANY ONLY)
NOTES TO CONDENSED FINANCIAL INFORMATION
The condensed parent company financial statements have been prepared in accordance with Rule 12-04, Schedule I of Regulation S-X as the restricted net assets of IQVIA Holdings Inc.’s (the “Company”) wholly owned subsidiary, IQVIA Incorporated exceed 25% of the consolidated net assets of the Company. These condensed parent company financial statements are not the general-purpose financial statements of the reporting entity. The ability of IQVIA Incorporated to pay dividends may be limited due to the restrictive covenants in the agreements governing its credit arrangements.
These condensed parent company financial statements include the accounts of IQVIA Holdings Inc. on a standalone basis (the “Parent”) and the equity method of accounting is used to reflect ownership interest in its subsidiary. Refer to the consolidated financial statements and notes presented elsewhere herein for additional information and disclosures with respect to these financial statements.
Below is a summary of the dividends paid to the Parent by IQVIA Incorporated in the years ended December 31, 2024, 2023 and 2022:
| (in millions) | Amount | |||||||
| Paid in December 2024 | $ | 200 | ||||||
| Paid in November 2024 | 952 | |||||||
| Paid in October 2024 | 11 | |||||||
| Paid in September 2024 | 201 | |||||||
| Paid in August 2024 | 1 | |||||||
| Paid in February 2024 | 58 | |||||||
| Total paid in 2024 | $ | 1,423 | ||||||
| Paid in November 2023 | $ | 232 | ||||||
| Paid in September 2023 | 55 | |||||||
| Paid in August 2023 | 89 | |||||||
| Paid in May 2023 | 490 | |||||||
| Paid in March 2023 | 130 | |||||||
| Paid in February 2023 | 56 | |||||||
| Total paid in 2023 | $ | 1,052 | ||||||
| Paid in December 2022 | $ | 25 | ||||||
| Paid in November 2022 | 3 | |||||||
| Paid in October 2022 | 40 | |||||||
| Paid in September 2022 | 110 | |||||||
| Paid in August 2022 | 1 | |||||||
| Paid in July 2022 | 100 | |||||||
| Paid in June 2022 | 188 | |||||||
| Paid in May 2022 | 303 | |||||||
| Paid in April 2022 | 2 | |||||||
| Paid in March 2022 | 125 | |||||||
| Paid in February 2022 | 322 | |||||||
| Paid in January 2022 | 20 | |||||||
| Total paid in 2022 | $ | 1,239 |
Schedule II—Valuation and Qualifying Accounts
Deferred Tax Asset Valuation Allowance
| Additions | ||||||||||||||||||||||||||||||||
| (in millions) | Balance at Beginning of Year | Charged to Expenses | Charged to Other Accounts(a) | Additions (Deductions) (b) | Balance at End of Year | |||||||||||||||||||||||||||
| December 31, 2024 | $ | 166 | $ | (12) | $ | — | $ | 42 | $ | 196 | ||||||||||||||||||||||
| December 31, 2023 | $ | 257 | $ | (99) | $ | — | $ | 8 | $ | 166 | ||||||||||||||||||||||
| December 31, 2022 | $ | 294 | $ | (27) | $ | — | $ | (10) | $ | 257 |
(a)Recorded through purchase accounting transaction.
(b)Impact of additions or reductions recorded to expense and translation adjustments.
Previous: Item 15. Exhibits and Financial Statement Schedules